Efficacy and safety analysis of belimumab for 28 weeks in real-world Chinese children with systemic lupus ery-thematosus:a retrospective multicenter pilot study

Multi-center Research Collaboration Group,Pediatric Allergy Immunology Rheumatology Branchthe Asia-Pacific Association of Medicine and Bio-Immunology,(PAIRB-APAMBI); Editorial Committee of Chinese Journal of Practical Pediatrics

doi:10.19538/j.ek2021110612

Home>Articles>Efficacy and safety analysis of belimumab for 28 weeks in real-world Chinese children with systemic lupus ery-thematosus:a retrospective multicenter pilot study

DOI: 10.19538/j.ek2021110612

Efficacy and safety analysis of belimumab for 28 weeks in real-world Chinese children with systemic lupus ery-thematosus:a retrospective multicenter pilot study

Multi-center Research Collaboration Group,Pediatric Allergy Immunology Rheumatology Branchthe Asia-Pacific Association of Medicine and Bio-Immunology,(PAIRB-APAMBI)

Editorial Committee of Chinese Journal of Practical Pediatrics

Machine-generated Keywords：

Publication Date：2021-11-06

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：11( 858-868 )

Chinese Journal of Practical Pediatrics

ISTICPKU

ISSN：1005-2224

Year, Vol.(Issue)：2021,36(11)